Apellis Pharmaceuticals News

Apellis Pharmaceuticals | DEF 14A: Definitive information statements

16:35 ET

Apellis Pharmaceuticals | ARS: Annual Report to Security Holders

16:19 ET

Apellis Pharmaceuticals | DEFA14A: Others

16:18 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Apr 19 19:30 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair

Apr 15 16:15 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal

Apr 9 16:30 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 8 16:20 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene

Apr 2 16:14 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Apr 1 11:26 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair

Mar 20 17:23 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 19 16:13 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DeLong Mark Jeffrey

Mar 19 16:09 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chopas James George

Mar 18 16:21 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 18 12:55 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 15 15:27 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nicholson Nur

Mar 14 16:25 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 13 16:40 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal

Mar 11 16:16 ET

Apellis Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Mar 8 16:12 ET

Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Watson David O.

Mar 8 07:50 ET